Chemoinformaics analysis of Ethyl 2-hydroxy-3-methylpentanoate
| Molecular Weight | 160.213 | nRot | 4 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 1 |
| Exact Molecular Weight | 160.11 | nRing | 0 |
| Solubility: LogS | -1.302 | nHRing | 0 |
| Solubility: LogP | 1.464 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 26.4347 |
| nHD | 1 | BPOL | 18.6553 |
| QED | 0.623 |
| Synth | 2.886 |
| Natural Product Likeliness | 0.702 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.011 |
| HIA | 0.003 |
| CACO-2 | -4.265 |
| MDCK | 0.0000649 |
| BBB | 0.978 |
| PPB | 0.441751 |
| VDSS | 0.971 |
| FU | 0.667542 |
| CYP1A2-inh | 0.314 |
| CYP1A2-sub | 0.444 |
| CYP2c19-inh | 0.061 |
| CYP2c19-sub | 0.832 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.417 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.277 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.279 |
| CL | 9.42 |
| T12 | 0.746 |
| hERG | 0.021 |
| Ames | 0.014 |
| ROA | 0.018 |
| SkinSen | 0.145 |
| Carcinogencity | 0.027 |
| EI | 0.969 |
| Respiratory | 0.096 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.928387 |